Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/20/2025

Mechanism of Action of Haloperidol on Dopamine Receptors

Primary Mechanism

  • Haloperidol functions as a central nervous system (CNS) dopamine receptor antagonist, with its main action occurring at the D2 receptors 1, 2
  • The blockade of D2 receptors in the nigrostriatal pathways and spinal cord via extrapyramidal pathways produces muscle rigidity and tremor, which explains some of haloperidol's side effects 1
  • Haloperidol's antagonism of D2 receptors in the hypothalamus affects temperature regulation by producing an increased set point and loss of heat-dissipating mechanisms 1

Receptor Specificity

  • Haloperidol is classified as a "high-potency" typical antipsychotic, which means it has strong D2 receptor blocking effects with less sedation but higher risk of extrapyramidal symptoms compared to "low-potency" agents 2
  • Unlike atypical antipsychotics, haloperidol does not significantly block serotonin receptors, which explains its different side effect profile 2

Clinical Implications of Receptor Binding

  • Haloperidol's strong D2 receptor antagonism is responsible for its efficacy in treating acute agitation and psychosis 3
  • The blockade of D2 receptors can lead to serious adverse effects like neuroleptic malignant syndrome (NMS), which is attributed to the lack of dopaminergic activity in the CNS 1
  • Extrapyramidal symptoms such as drug-induced parkinsonism, akathisia, and tardive dyskinesia are direct consequences of D2 receptor blockade in the nigrostriatal pathway 1

Common Pitfalls and Caveats

  • Haloperidol's D2 receptor antagonism can cause significant extrapyramidal side effects, which may require treatment with anticholinergic agents or dopaminergic agonists 1